DIA
CRDF icon

Denver Investment Advisors’s Cardiff Oncology CRDF Stock Holding History

Denver Investment Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-605
Closed -$152K – 612
2014
Q2 		$152K Buy
605
+338
+127% +$108K ﹤0.01% 576
2014
Q1 		$110K Buy
267
+92
+53% +$39.8K ﹤0.01% 596
2013
Q4 		$72 Hold
175
– – ﹤0.01% 569
2013
Q3 		$91K Buy
+175
New +$99.7K ﹤0.01% 566

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Denver Investment Advisors's CRDF Position: Q3 2014 in Review

Denver Investment Advisors sold out of Cardiff Oncology (CRDF) in Q3 2014, closing a stake of 605 shares — an estimated $152K sold.

Denver Investment Advisors first reported a position in CRDF in Q3 2013 and held it in 4 quarters. The position peaked at $152K in Q2 2014. 22 funds tracked by Wall St. Rank hold CRDF as of Q3 2014.

  • Denver Investment Advisors reported no remaining Cardiff Oncology position as of Q3 2014 after selling out during the quarter.
  • Denver Investment Advisors sold 605 Cardiff Oncology shares in Q3 2014, an estimated $152K.
  • Denver Investment Advisors first reported a position in Cardiff Oncology in Q3 2013 and held it in 4 quarters.
  • Denver Investment Advisors's Cardiff Oncology position peaked at $152K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2014.

Based on Denver Investment Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.